Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2016 August;151(4) > Giornale Italiano di Dermatologia e Venereologia 2016 August;151(4):436-40

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

CASE REPORTS   

Giornale Italiano di Dermatologia e Venereologia 2016 August;151(4):436-40

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Successful management of angiolymphoid hyperplasia with eosinophilia in a split-face trial of topical tacrolimus and timolol solution

Anna CHACON 1, Jessica MERCER 2

1 Department of Dermatology and Cutaneous Surgery, Orlando Regional Medical Center, University of Central Florida College of Medicine, Orlando, FL, USA; 2 Department of Dermatology, Albert Einstein School of Medicine, Yeshiva University, New York, NY, USA


PDF


Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon, benign condition characterized by multiple benign angiomatous nodules or plaques. Cutaneous lesions can be painful, pruritic, pulsatile, or potentially disfiguring resulting in significant morbidity. ALHE is a pathologic diagnosis featuring proliferations of capillary-sized vessels with epithelioid endothelial cells surrounded by larger, thick-walled vessels and accompanying eosinophils and lymphocytes. Surgery is generally required, however the skin lesions often recur after excision. ALHE is notoriously difficult to treat and many physicians would prefer a non-invasive treatment of choice. We report a case of ALHE that was successfully treated with the novel use of topical tacrolimus in a split-face trial with topical timolol solution.

top of page